For information on this past event please contact Meetings Management

Second Circular and Provisional Conference Program

The Third International Conference on

Immunopotentiators in Modern Vaccines
21-23 May 2008, Half Moon Resort, Montego Bay, Jamaica

Scientific Advisory Panel/Moderators

Conference Co-Chairmen:
Virgil Schijns (Intervet BV, The Netherlands)
Jim Brewer (University of Strathclyde, Glasgow, UK)

Jan Holmgren (University of Gothenberg, Sweden)
Derek O’Hagan (Novartis Vaccines, Siena, Italy)
Philippe Moingeon (Stallergenes SA, Antony, France)
Filippo Belardelli (ISS, Rome, Italy)
Luke O’Neill (Trinity College Dublin, Ireland)
Gwyn Davies (St. George’s University of London, UK)
Martin Bachmann (Cytos Biotechnology, Zurich, Switzerland)
Brian Ledwith (MERCK, West Point, USA)
Thea Sesardic (NIBSC, Potters Bar, UK)
Debbie Drane (CSL Limited, Australia)
Ali Harandi (Gothenburg University, Sweden)
Alex von Gabain (Intercell AG, Vienna Austria)
Rob Lambkin-Williams (Retroscreen Virology, London, UK)
Jedd Wolchok (MSKCC, New York, USA)

IMV 2008 is the follow-up to the successful IMV meetings held in Prague in 2002 and Spain 2005. The IMV conference series offers a regular update on the developments/issues surrounding ‘immunopotentiators for modern vaccines’ and is a vital aspect of the growth of this important area of vaccinology.

IMV 2008 will once again offer an international forum to review the current state of research and developments/applications of immunopotentiators/adjuvants for modern vaccines and associated vaccine programmes/strategies. IMV 2008 will be of interest to researchers involved in determining the mechanisms of adjuvant function and responses and optimising these responses, manufacturers of biologicals, those involved in the manufacture/licensing of injectable biologicals, and those interested in the control of infectious and non/infectious diseases.

Special Poster Session

IMV 2008 will, for the first time, include a special poster session, where selected poster paper authors will be invited to make short oral presentations of their poster paper to the IMV 2008 audience. Further details will be given on formal acceptance for POSTER presentation.

Closing date for poster abstract submissions Friday 4th April 2008)

Sponsored by